Claudia Guerrieri
Claudia Guerrieri
Explore linked clinical trials.1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Pembrolizumab-Sacituzumab Govitecan Combination to Treat High-risk, Localized Bladder Cancer | Muscle-invasive Urothelial Carcinoma of the Bladder | Active, not recruiting | Phase 2 | 2025-04-02 | NCT05535218 |